Top

Published in:

01-06-2017 | Original Article

Effect of CD40/CD40L signaling on IL-10-producing regulatory B cells in Chinese children with Henoch-Schönlein purpura nephritis

Authors: Baohui Yang, Xiongjun Tan, Xiao Xiong, Daoqi Wu, Gaofu Zhang, Mo Wang, Shifang Dong, Wei Liu, Haiping Yang, Qiu Li

Published in: Immunologic Research | Issue 3/2017

Abstract

The aim of the present study was to examine the role and mechanism of interleukin-10 (IL-10)-producing regulatory B cells (B10 cells) in the pathogenesis of Henoch-Schönlein purpura nephritis (HSPN). We examined the percentage of B10 cells, CD19⁺CD24^hiCD38^hi B cells, CD19⁺CD24^hiCD27⁺ B cells, Th17 cells, and T regulatory (Treg) cells within the peripheral blood mononuclear cell (PBMC) population in healthy subjects and HSP/HSPN patients. The percentage of B10 cells and CD19⁺CD24^hiCD38^hi B cells was reduced in HSPN patients and that of CD19⁺CD24^hiCD27⁺ B cells was decreased only in HSPN patients with hematuria and proteinuria or massive proteinuria. The expression of IL-10 by B10 cells and their subsets was decreased in HSPN patients and returned to normal levels in HSP/HSPN patients in remission. B10 cells and their subsets negatively correlated with the Th17/Treg ratio. There was no difference in B10pro + B10 cells, Th17 cells, Treg cells, and the Th17/Treg ratio between children with HSP/HSPN and healthy controls after CD40L stimulation. On the other hand, the level of IL-10 expressed by CD19⁺CD40⁺ B cells was decreased in HSPN, and the percentage of B10pro + B10 cells and Treg cells was reduced and that of Th17 cell was increased in the presence of anti-CD40L monoclonal antibody (mAb). Thus, decreased B10 cells and CD19⁺CD24^hiCD38^hi B cells may function as an early marker of renal impairment in HSPN. The dysfunction of B10 cells may play a role in the pathogenesis of HSPN by regulating the Th17/Treg balance. Moreover, the CD40/CD40L signaling pathway may play a role in B10 cell differentiation and functional maturation.

Calvino MC, Llorca J, Garcia-Porrua C, Fernandez-Iglesias JL, Rodriguez-Ledo P, Gonzalez-Gay MA. Henoch-Schonlein purpura in children from northwestern Spain: a 20-year epidemiologic and clinical study. Medicine (Baltimore). 2001;80:279–90.CrossRef

Chang H, Yu DS, Liu XQ, Zhang QY, Cheng N, Zhang SQ, Qu ZH. Clinical significance of TLR3 and TLR4 in peripheral blood mononuclear cells from children with Henoch-Schönlein purpura nephritis. Exp Ther Med. 2014;7:1703–7.PubMedPubMedCentral

Mir S, Yavascan O, Mutlubas F, Yeniay B, Sonmez F. Clinical outcome in children with Henoch-Schönlein nephritis. Pediatr Nephrol. 2007;22:64–70.CrossRefPubMed

Xia Y, Mao J, Chen Y, Wang D, Cao L, Yao S, Fu H, Du L, Liu A. Clinical outcomes in children with Henoch-Schönlein purpura nephritis grade IIIa or IIIb. Pediatr Nephrol. 2011;26:1083–8.CrossRefPubMed

González LM, Janniger CK, Schwartz RA. Pediatric Henoch-Schönlein purpura. Int J Dermatol. 2009;48:1157–65.CrossRefPubMed

Pohl M. Henoch-Schönlein purpura nephritis. Pediatr Nephrol. 2015;30:245–52.CrossRefPubMed

Saulsbury FT. Henoch-Schönlein purpura in children. Reports of 100 patients and review of theliterature. Medicine (Baltimore). 1999;78:395–409.CrossRef

Jen HY, Chuang YH, Lin SC, Chiang BL, Yang YH. Increased serum interleukin-17 and peripheral Th17 cells in children with acute Henoch-Schönlein purpura. Pediatr Allergy Immunol. 2011;22:862–8.CrossRefPubMed

Yang YH, Chuang YH, Wang LC, Huang HY, Gershwin ME, Chiang BL. The immunobiology of Henoch-Schönlein purpura. Autoimmun Rev. 2008;7:179–84.CrossRefPubMed

10.

Li YY, Li CR, Wang GB, Yang J, Zu Y. Investigation of the change in CD4⁺ T cell subset in children with Henoch-Schonlein purpura. Rheumatol Int. 2012;32:3785–92.CrossRefPubMed

11.

Yang J, Li CR, Wang GB, Huang HJ, Zu Y, Li YB. Role of Th17 cell and CD4⁺CD2⁵⁺regulatory T cells in pathogenesis of Henoch-Schonlein purpura in children. J Clin Pediatr. 2009;27:645–8.

12.

Chen O, Zhu XB, Ren H, Wang YB, Sun R. The imbalance of Th17/Treg in Chinese children with Henoch-Schonlein purpura. Int Immunopharmacol. 2013;16:67–71.CrossRefPubMed

13.

Sinha A, Bagga A. Nephrotic syndrome. Indian J Pediatr. 2012;79:1045–55.CrossRefPubMed

14.

LeBien TW, Tedder TF. B-lymphocytes: how they develop and function. Blood. 2008;112:1570–80.CrossRefPubMedPubMedCentral

15.

Yanaba K, Kamata M, Asano Y, Tada Y, Sugaya M, Kadono T, Tedder TF, Sato S. CD19 expression in B cells regulates atopic dermatitis in a mouse model. Am J Pathol. 2013;182:2214–22.CrossRefPubMedPubMedCentral

16.

Carter NA, Rosser EC, Mauri C. Interleukin-10 produced by B cells is crucial for the suppression of Th17/Th1 responses, induction of T regulatory type 1 cells and reduction of collagen-induced arthritis. Arthritis Res Ther. 2012;14(1):R32.CrossRefPubMedPubMedCentral

17.

Anolik JH, Barnard J, Owen T, Zheng B, Kemshetti S, Looney RJ, Sanz I. Delayed memory B cell recovery in peripheral blood and lymphoid tissue in systemic lupus erythematosus after B cell depletion therapy. Arthritis Rheum. 2007;56:3044–56.CrossRefPubMed

18.

Mauri C, Gray D, Mushtaq N, Londei M. Prevention of arthritis by interleukin 10-producing B cells. J Exp Med. 2003;197:489–501.CrossRefPubMedPubMedCentral

19.

Correale J, Farez M, Razzitte G. Helminth infections associated with multiple sclerosis induce regulatory B cells. Ann Neurol. 2008;64:187–99.CrossRefPubMed

20.

Iwata Y, Matsushita T, Horikawa M, Dilillo DJ, Yanaba K, Venturi GM, et al. Characterization of a rare IL-10-competent B-cell subset in humans that parallels mouse regulatory B10 cells. Blood. 2011;117:530–41.CrossRefPubMedPubMedCentral

21.

Flores-Borja F, Bosma A, Ng D, Reddy V, Ehrenstein MR, Isenberg DA, Mauri C. CD19⁺CD24^hiCD38^hi B cells maintain regulatory T cells while limiting TH1 and TH17 differentiation. Sci Transl Med. 2013;5:173ra123.CrossRef

22.

Blair PA, Norena LY, Flores-Borja F, Rawlings DJ, Isenberg DA, Ehrenstein MR, Mauri C. CD19⁽⁺⁾CD24^(hi)CD38^(hi) B cells exhibit regulatory capacity in healthy individuals but are functionally impaired in systemic lupus erythematosus patients. Immunity. 2010;32:129–40.CrossRefPubMed

23.

Liu BS, Cao Y, Huizinga TW, Hafler DA, Toes RE. TLR-mediated STAT3 and ERK activation controls IL-10 secretion by human B cells. Eur J Immunol. 2014;44:2121–9.CrossRefPubMed

24.

Ozen S, Ruperto N, Dillon MJ, et al. EULAR/PReS endorsed consensus criteria for the classification of childhood vasculitides. Ann Rheum Dis. 2006;65:936–41.CrossRefPubMed

25.

Sumimoto K, Uchida K, Kusuda T, Mitsuyama T, Sakaguchi Y, Fukui T, Matsushita M, Takaoka M, Nishio A, Okazaki K. The role of CD19⁺ CD24^high CD38^high and CD19⁺ CD24^high CD27⁺ regulatory B cells in patients with type 1 autoimmune pancreatitis. Pancreatology. 2014;14:193–200.CrossRefPubMed

26.

Du HQ, Zhang X, An YF, Ding Y, Zhao XD. Effects of Wiskott-Aldrich syndrome protein deficiency on IL-10-producing regulatory B cells in humans and mice. Scand J Immunol. 2015;81:483–93.CrossRefPubMed

27.

Yanaba K, Bouaziz JD, Haas KM, Poe JC, Fujimoto M, Tedder TF. A regulatory B cell subset with a unique CD1d^hiCD5⁺ phenotype controls T cell-dependent inflammatory responses. Immunity. 2008;28:639–50.CrossRefPubMed

28.

Yang M, Deng J, Liu Y, Ko KH, Wang X, Jiao Z, Wang S, Hua Z, Sun L, Srivastava G, Lau CS, Cao X, Lu L. IL-10-producing regulatory B10 cells ameliorate collagen-induced arthritis via suppressing Th17 cell generation. Am J Pathol. 2012;180:2375–85.CrossRefPubMed

29.

Gu Y, Yang J, Ouyang X, Liu W, Li H, Yang J, Bromberg J, Chen SH, Mayer L, Unkeless JC, Xiong H. Interleukin 10 suppresses Th17 cytokines secreted by macrophages and T cells. Eur J Immunol. 2008;38:1807–13.CrossRefPubMedPubMedCentral

30.

Matsushita T, Yanaba K, Bouaziz JD, Fujimoto M, Tedder TF. Regulatory B cells inhibit EAE initiation in mice while other B cells promote disease progression. J Clin Invest. 2008;118:3420–30.PubMedPubMedCentral

31.

Hoehlig K, Shen P, Lampropoulou V, Roch T, Malissen B, O’Connor R, Ries S, Hilgenberg E, Anderton SM, Fillatreau S. Activation of CD4⁺Foxp3⁺regulatory T cells proceeds normally in the absence of B cells during EAE. Eur J Immunol. 2012;42:1164–73.CrossRefPubMed

32.

Carter NA, Vasconcellos R, Rosser EC, Tulone C, Muñoz-Suano A, Kamanaka M, Ehrenstein MR, Flavell RA, Mauri C. Mice lacking endogenous IL-10-producing regulatory B cells develop exacerbated disease and present with an increased frequency of Th1/Th17 but a decrease in regulatory T cells. J Immunol. 2011;186:5569–79.CrossRefPubMed

33.

Amu S, Saunders SP, Kronenberg M, Mangan NE, Atzberger A, Fallon PG. Regulatory B cells prevent and reverse allergic airway inflammation via Foxp3-positive T regulatory cells in a murine model. J Allergy Clin Immunol. 2010;125:1114–24.CrossRefPubMed

34.

Sun JB, Flach CF, Czerkinsky C, Holmgren J. B lymphocytes promote expansion of regulatory T cells in oral tolerance: powerful induction by antigen coupled to cholera toxin B subunit. J Immunol. 2008;181:8278–87.CrossRefPubMed

35.

Sayi A, Kohler E, Toller IM, Flavell RA, Müller W, Roers A, Müller A. TLR-2-activated B cells suppress Helicobacter-induced preneoplastic gastric immunopathology by inducing T regulatory-1 cells. J Immunol. 2011;186:878–90.CrossRefPubMed

36.

Mizoguchi A, Bhan AK. A case for regulatory B cells. J Immunol. 2006;176:705–10.CrossRefPubMed

37.

Mizoguchi A, Mizoguchi E, Takedatsu H, Blumberg RS, Bhan AK. Chronic intestinal inflammatory condition generates IL-10-producing regulatory B cell subset characterized by CD1d upregulation. Immunity. 2002;16:219–30.CrossRefPubMed

38.

Kleffel S, Vergani A, Tezza S, Ben Nasr M, Niewczas MA, Wong S, Bassi R, D’Addio F, Schatton T, Abdi R, Atkinson M, Sayegh MH, Wen L, Wasserfall CH, O’Connor KC, Fiorina P. Interleukin-10⁺ regulatory B cells arise within antigen-experienced CD40⁺ B cells to maintain tolerance to islet autoantigens. Diabetes. 2015;64:158–71.CrossRefPubMed

39.

Kamei K, Ogura M, Sato M, Ito S, Ishikura K. Evolution of IgA nephropathy into anaphylactoid purpura in six cases—further evidence that IgA nephropathy and Henoch-Schonlein purpura nephritis share common pathogenesis. Pediatr Nephrol. 2016;31:779–85.CrossRefPubMed

40.

Lin FJ, Jiang GR, Shan JP, Zhu C, Zou J, Wu XR. Imbalance of regulatory T cells to Th17 cells in IgA nephropathy. Scand J Clin Lab Invest. 2012;72:221–9.CrossRefPubMed

41.

Zhang X, Wu X, Xiong L, Yi Z, He Q, He X, Mo S. Role of vitamin D3 in regulation of T helper cell 17 and regulatory T-cell balance in rats with immunoglobulin a nephropathy. Iran J Kidney Dis. 2014;8:363–70.PubMed

42.

Wang YY, Zhang L, Zhao PW, Ma L, Li C, Zou HB, Jiang YF. Function implications of regulatory B cells in human IgA nephropathy. Scand J Immunol. 2014;79:51–60.CrossRefPubMed

Title: Effect of CD40/CD40L signaling on IL-10-producing regulatory B cells in Chinese children with Henoch-Schönlein purpura nephritis
Authors: Baohui Yang
Xiongjun Tan
Xiao Xiong
Daoqi Wu
Gaofu Zhang
Mo Wang
Shifang Dong
Wei Liu
Haiping Yang
Qiu Li
Publication date: 01-06-2017
Publisher: Springer US
Published in: Immunologic Research / Issue 3/2017
Print ISSN: 0257-277X
Electronic ISSN: 1559-0755
DOI: https://doi.org/10.1007/s12026-016-8877-8

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Effect of CD40/CD40L signaling on IL-10-producing regulatory B cells in Chinese children with Henoch-Schönlein purpura nephritis

Abstract

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Abstract

Please log in to get access to this content

Other articles of this Issue 3/2017

LPS-treated bone marrow-derived dendritic cells induce immune tolerance through modulating differentiation of CD4+ regulatory T cell subpopulations mediated by 3G11 and CD127

NLRP3 inflammasome activation regulated by NF-κB and DAPK contributed to paraquat-induced acute kidney injury

Myeloid cells expressing high level of CD45 are associated with a distinct activated phenotype in glioma

A population association study of vitamin D receptor gene polymorphisms and haplotypes with the risk of systemic lupus erythematosus in a Chinese population

Retrospective analysis of 55 twin neonates with haemolytic disease of the newborn

Neutralization of nerve growth factor (NGF) inhibits the Th2 response and protects against the respiratory syncytial virus (RSV) infection